Clinical Research, Pharma & Healthcare FinancingDaiichi Sankyo, GENESIS Pharma Agree on VANFLYTA® in CEEBusiness WireJanuary 7, 2026January 8, 2026 by Business WireJanuary 7, 2026January 8, 2026010 Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13...